| ||||||||||||||||||||
Loss of Insulin-Like Growth Factor-II Imprinting and the Presence of Screen-Detected Colorectal Adenomas in Women The following information about the CONCeRN trial accompanies the Brief Communication by Woodson et al., J Natl Cancer Inst 2004;96:407–10: Files in this Data Supplement:
J. Natl. Cancer Inst. Woodson et al.
96: 407
Supplemental Data
| ||||||||||||||||||||